Investigational Clinical Trials for Prostate Cancer

We’re committed to our mission of finding new treatments that may help improve the lives of people with cancer. Our clinical trials for prostate cancer study investigational medications alone, or in combination with other study medications, or standard of care therapy. We perform these trials to see if they can help prevent, find, or treat cancer.

Prostate cancer begins when cells inside the prostate gland start to grow rapidly. As more cancer cells grow, they form a tumor and can potentially spread to other areas of the body.

Cancer that has spread beyond the prostate is known as metastatic prostate cancer. Male hormones (such as testosterone) help prostate cancer grow, so men with metastatic prostate cancer usually get hormone therapy as their first treatment. This treatment aims to lower the body’s levels of male hormones to shrink the cancer in the prostate and other areas where it has spread. However, prostate cancer may eventually grow and require more treatments to help stop or slow down the disease. This is when the prostate cancer is called metastatic castration resistant prostate cancer (mCRPC).